SlideShare a Scribd company logo
1 of 34
Drugs Affecting Gastrointestinal 
Motility 
Chapter 58 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Actions of Drugs Used to Affect Motor 
Activity of the GI Tract 
• Speed up or improve movement of intestinal contents 
when movement becomes slow or sluggish (constipation) 
• Increase the tone of the GI tract and stimulate motility 
throughout the system 
• Decrease movement along the GI tract when rapid 
movement decreases the time for absorption of nutrients 
(diarrhea) 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Sites of Action of Drugs Affecting GI 
Motility 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Types of Laxatives 
• Chemical Stimulants 
– Chemically irritate the lining of the GI tract 
• Bulk Stimulants 
– Cause the fecal matter to increase in bulk 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Lubricants 
– Help the intestinal contents move more smoothly
Types of Chemical Stimulants 
• Cascara (Generic): Reliable agent that leads to intestinal 
evacuation 
• Senna (Senokot): Reliable drug, similar to cascara (OTC) 
• Castor Oil (Neoloid): Old standby for thorough evacuation 
of the intestine 
• Bisacodyl (Dulcolax): Very popular OTC laxative 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Types of Bulk Stimulants 
• Magnesium Sulfate (Epsom Salts) 
• Magnesium Citrate (Citrate of Magnesia) 
• Magnesium Hydroxide (Milk of Magnesia) 
• Lactulose (Chronulac) 
• Polycarbophil (FiberCon) 
• Psyllium (Metamucil) 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Types of Lubricating Laxatives 
• Docusate (Colace) 
– Has a detergent action on the surface of the 
intestinal bolus, making a softer stool 
• Glycerin (Sani-Supp) 
– Hyperosmolar laxative used to gently evacuate the 
rectum without systemic effects higher in the GI tract 
• Mineral Oil (Agoral Plain) 
– Forms a slippery coat on the contents of the 
intestinal tract 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Laxatives 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Work in three ways: 
• Direct chemical stimulation of the GI tract 
• Production of bulk or increased fluid in the lumen 
• Lubrication of the intestinal bolus to promote passage 
through the GI tract 
• Indications 
– Short-term relief of constipation 
– Prevent straining when it is clinically undesirable 
– Evacuate the bowel for diagnostic procedures 
– Removal of ingested poisons 
– Adjunct in antihelmintic therapy
Laxatives (cont.) 
• Pharmacokinetics 
– Only minimally absorbed and exert their therapeutic 
effect directly in the GI tract 
• Contraindications 
– Acute abdominal disorders 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Caution 
– Pregnancy or lactation
Laxatives (cont.) 
• Adverse Effects 
– GI effects - Diarrhea, abdominal cramping, and 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
nausea 
– CNS effects – Dizziness, headache, and weakness 
– CV effects – Sweating, palpitations, flushing, and 
fainting 
– Cathartic dependency 
• Drug-to-Drug Interactions 
– Some interfere with the timing or process of 
absorption
Question 
Which of the following is a very popular OTC laxative? 
A. Cascara 
B. Magnesium citrate 
C. Bisacodyl 
D. Polycarbophil 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Answer 
C. Bisacodyl 
Rationale: Bisacodyl (Dulcolax): Very popular OTC laxative. 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Types of Gastrointestinal Stimulants 
• Dexpanthenol (Ilopan) 
– Increases acetylcholine levels and stimulates the 
parasympathetic system 
• Metoclopramide (Reglan) 
– Blocks dopamine receptors and makes the GI cells 
more sensitive to acetylcholine 
– Leads to increased GI activity and rapid movement of 
food through the upper GI tract 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Gastrointestinal Stimulants 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Stimulate parasympathetic activity within the GI 
tract 
– Increase GI secretions and motility 
• Indications 
– Rapid movement of GI contents is desirable 
• Pharmacokinetics 
– Rapidly absorbed 
– Metabolized in the liver 
– Excreted in the urine
Gastrointestinal Stimulants (cont.) 
• Contraindications 
– Allergy 
– GI obstruction 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Caution 
– Pregnancy 
– Lactation
Gastrointestinal Stimulants (cont.) 
• Adverse Effects 
– Nausea, vomiting, diarrhea, intestinal spasms, 
cramping, decreased blood pressure and heart rate, 
weakness, and fatigue 
• Drug-to-Drug Interactions 
– Digoxin 
– Cyclosporine 
– Alcohol 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Types of Antidiarrheal Drugs 
• Bismuth Subsalicylate (Pepto-Bismol): Coats the lining of 
the GI tract and soothes irritation stimulating local 
reflexes to cause excessive GI activity and diarrhea 
• Loperamide (Imodium): Has a direct effect on the muscle 
layers of the GI tract; slows peristalsis and allows 
increased time for absorption of fluid and electrolytes 
• Opium Derivatives (Paregoric): Stimulates spasm within 
the GI tract, stops peristalsis and diarrhea 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Antidiarrheal Drugs 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Slow the motility of the GI tract through direct action 
on the lining of the GI tract 
• Indications 
– Relief of symptoms of acute or chronic diarrhea 
– Reduction of volume of discharge from ileostomies 
– Prevention and treatment of traveler’s diarrhea 
• Pharmacokinetics 
– Vary depending on agent
Antidiarrheal Drugs (cont.) 
• Contraindications 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
– Allergy 
• Caution 
– Pregnancy 
– Lactation 
– History of GI obstruction 
– History of acute abdominal conditions 
– Diarrhea due to poisonings
Antidiarrheal Drugs (cont.) 
• Adverse Effects 
– Constipation 
– Abdominal distension 
– Abdominal discomfort 
– Nausea 
– Dry mouth 
– Toxic megacolon 
– Fatigue 
– Weakness 
– Dizziness 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Antidiarrheal Drugs (cont.) 
• Drug-to-Drug Interactions 
– Depends on the drug 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Question 
Please answer the following statement as true or false. 
Pepto-Bismol can be involved in salicylate toxicity. 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Answer 
True 
Rationale: Bismuth Subsalicylate (Pepto-Bismol) coats the 
lining of the GI tract and soothes irritation stimulating 
local reflexes to cause excessive GI activity and diarrhea. 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Use of Laxative and Antidiarrheal Agents 
Across the Lifespan 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Chemical Stimulant Laxative 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Bulk Laxative 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Lubricant Laxative 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Gastrointestinal Stimulants 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Antidiarrheal Drugs 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Laxatives 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for 
Gastrointestinal Stimulants 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Antidiarrheal 
Drugs 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Question 
Why should laxatives be taken only on a short-term basis? 
A. To prevent a fluid volume deficit 
B. To prevent cathartic dependence 
C. To obtain relief of abdominal distention 
D. To obtain relief of intestinal cramping 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Answer 
B. To prevent cathartic dependence 
Rationale: Administer laxative only as a temporary 
measure to prevent development of cathartic 
dependence. 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

More Related Content

What's hot

What's hot (17)

Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59
 
Ppt chapter 32-1
Ppt chapter 32-1Ppt chapter 32-1
Ppt chapter 32-1
 
Ppt chapter 33
Ppt chapter 33Ppt chapter 33
Ppt chapter 33
 
Ppt chapter 30-1
Ppt chapter 30-1Ppt chapter 30-1
Ppt chapter 30-1
 
Chapter030
Chapter030Chapter030
Chapter030
 
Chapter031
Chapter031Chapter031
Chapter031
 
Ppt chapter 26-1
Ppt chapter 26-1Ppt chapter 26-1
Ppt chapter 26-1
 
Chapter032
Chapter032Chapter032
Chapter032
 
Chapter039
Chapter039Chapter039
Chapter039
 
Ppt chapter 56
Ppt chapter 56Ppt chapter 56
Ppt chapter 56
 
Ppt chapter 29-1
Ppt chapter 29-1Ppt chapter 29-1
Ppt chapter 29-1
 
Ppt chapter 41
Ppt chapter 41Ppt chapter 41
Ppt chapter 41
 
Ppt chapter 57
Ppt chapter 57Ppt chapter 57
Ppt chapter 57
 
Ppt chapter 36-1
Ppt chapter 36-1Ppt chapter 36-1
Ppt chapter 36-1
 
Ppt chapter 25
Ppt chapter 25Ppt chapter 25
Ppt chapter 25
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1
 
Chapter040
Chapter040Chapter040
Chapter040
 

Viewers also liked

2. astringents & keratolytics
2. astringents & keratolytics2. astringents & keratolytics
2. astringents & keratolyticsIAU Dent
 
Anti diarrhoeals & laxative
Anti diarrhoeals & laxativeAnti diarrhoeals & laxative
Anti diarrhoeals & laxativeRahul B S
 
Laxative and antidiarrheal agents
Laxative and antidiarrheal agentsLaxative and antidiarrheal agents
Laxative and antidiarrheal agentsRahul B S
 

Viewers also liked (6)

Chapter008
Chapter008Chapter008
Chapter008
 
Siddharthppt 2
Siddharthppt 2Siddharthppt 2
Siddharthppt 2
 
Osmotic drug delivery system
Osmotic drug delivery systemOsmotic drug delivery system
Osmotic drug delivery system
 
2. astringents & keratolytics
2. astringents & keratolytics2. astringents & keratolytics
2. astringents & keratolytics
 
Anti diarrhoeals & laxative
Anti diarrhoeals & laxativeAnti diarrhoeals & laxative
Anti diarrhoeals & laxative
 
Laxative and antidiarrheal agents
Laxative and antidiarrheal agentsLaxative and antidiarrheal agents
Laxative and antidiarrheal agents
 

Similar to Ppt chapter 58

Ppt chapter 58
Ppt chapter 58Ppt chapter 58
Ppt chapter 58stanbridge
 
Ppt chapter 57
Ppt chapter 57Ppt chapter 57
Ppt chapter 57stanbridge
 
Ppt chapter 56
Ppt chapter 56Ppt chapter 56
Ppt chapter 56stanbridge
 
Ppt chapter 52
Ppt chapter 52Ppt chapter 52
Ppt chapter 52stanbridge
 
Ppt chapter 40
Ppt chapter 40Ppt chapter 40
Ppt chapter 40stanbridge
 
Ppt chapter 47
Ppt chapter 47Ppt chapter 47
Ppt chapter 47stanbridge
 
Ppt chapter 38-1
Ppt chapter 38-1Ppt chapter 38-1
Ppt chapter 38-1stanbridge
 
Ppt chapter 51
Ppt chapter 51Ppt chapter 51
Ppt chapter 51stanbridge
 
Ppt chapter 37
Ppt chapter 37Ppt chapter 37
Ppt chapter 37stanbridge
 
Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59stanbridge
 
Ppt chapter 38
Ppt chapter 38Ppt chapter 38
Ppt chapter 38stanbridge
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1stanbridge
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1stanbridge
 
Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36stanbridge
 
Ppt chapter 51-1
Ppt chapter 51-1Ppt chapter 51-1
Ppt chapter 51-1stanbridge
 
Ppt chapter 16
Ppt chapter 16Ppt chapter 16
Ppt chapter 16stanbridge
 
Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36stanbridge
 
Ppt chapter 16-1
Ppt chapter 16-1Ppt chapter 16-1
Ppt chapter 16-1stanbridge
 
Ppt chapter 37
Ppt chapter 37Ppt chapter 37
Ppt chapter 37stanbridge
 
Ppt chapter 35
Ppt chapter 35Ppt chapter 35
Ppt chapter 35stanbridge
 

Similar to Ppt chapter 58 (20)

Ppt chapter 58
Ppt chapter 58Ppt chapter 58
Ppt chapter 58
 
Ppt chapter 57
Ppt chapter 57Ppt chapter 57
Ppt chapter 57
 
Ppt chapter 56
Ppt chapter 56Ppt chapter 56
Ppt chapter 56
 
Ppt chapter 52
Ppt chapter 52Ppt chapter 52
Ppt chapter 52
 
Ppt chapter 40
Ppt chapter 40Ppt chapter 40
Ppt chapter 40
 
Ppt chapter 47
Ppt chapter 47Ppt chapter 47
Ppt chapter 47
 
Ppt chapter 38-1
Ppt chapter 38-1Ppt chapter 38-1
Ppt chapter 38-1
 
Ppt chapter 51
Ppt chapter 51Ppt chapter 51
Ppt chapter 51
 
Ppt chapter 37
Ppt chapter 37Ppt chapter 37
Ppt chapter 37
 
Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59
 
Ppt chapter 38
Ppt chapter 38Ppt chapter 38
Ppt chapter 38
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1
 
Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36
 
Ppt chapter 51-1
Ppt chapter 51-1Ppt chapter 51-1
Ppt chapter 51-1
 
Ppt chapter 16
Ppt chapter 16Ppt chapter 16
Ppt chapter 16
 
Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36
 
Ppt chapter 16-1
Ppt chapter 16-1Ppt chapter 16-1
Ppt chapter 16-1
 
Ppt chapter 37
Ppt chapter 37Ppt chapter 37
Ppt chapter 37
 
Ppt chapter 35
Ppt chapter 35Ppt chapter 35
Ppt chapter 35
 

More from stanbridge

Micro Lab 3 Lecture
Micro Lab 3 LectureMicro Lab 3 Lecture
Micro Lab 3 Lecturestanbridge
 
Creating a poster v2
Creating a poster v2Creating a poster v2
Creating a poster v2stanbridge
 
Creating a poster
Creating a posterCreating a poster
Creating a posterstanbridge
 
OT 5018 Thesis Dissemination
OT 5018 Thesis DisseminationOT 5018 Thesis Dissemination
OT 5018 Thesis Disseminationstanbridge
 
Ot5101 005 week 5
Ot5101 005 week 5Ot5101 005 week 5
Ot5101 005 week 5stanbridge
 
Ot5101 005 week4
Ot5101 005 week4Ot5101 005 week4
Ot5101 005 week4stanbridge
 
Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors stanbridge
 
Ch 5 developmental stages of the learner
Ch 5   developmental stages of the learnerCh 5   developmental stages of the learner
Ch 5 developmental stages of the learnerstanbridge
 
OT 5101 week2 theory policy
OT 5101 week2 theory policyOT 5101 week2 theory policy
OT 5101 week2 theory policystanbridge
 
OT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentOT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentstanbridge
 
NUR 304 Chapter005
NUR 304 Chapter005NUR 304 Chapter005
NUR 304 Chapter005stanbridge
 
NUR 3043 Chapter007
NUR 3043 Chapter007NUR 3043 Chapter007
NUR 3043 Chapter007stanbridge
 
NUR 3043 Chapter006
NUR 3043 Chapter006NUR 3043 Chapter006
NUR 3043 Chapter006stanbridge
 
NUR 3043 Chapter004
NUR 3043 Chapter004NUR 3043 Chapter004
NUR 3043 Chapter004stanbridge
 
3043 Chapter009
3043 Chapter0093043 Chapter009
3043 Chapter009stanbridge
 
3043 Chapter008
 3043 Chapter008 3043 Chapter008
3043 Chapter008stanbridge
 
Melnyk ppt chapter_21
Melnyk ppt chapter_21Melnyk ppt chapter_21
Melnyk ppt chapter_21stanbridge
 
Melnyk ppt chapter_22
Melnyk ppt chapter_22Melnyk ppt chapter_22
Melnyk ppt chapter_22stanbridge
 

More from stanbridge (20)

Micro Lab 3 Lecture
Micro Lab 3 LectureMicro Lab 3 Lecture
Micro Lab 3 Lecture
 
Creating a poster v2
Creating a poster v2Creating a poster v2
Creating a poster v2
 
Creating a poster
Creating a posterCreating a poster
Creating a poster
 
Sample poster
Sample posterSample poster
Sample poster
 
OT 5018 Thesis Dissemination
OT 5018 Thesis DisseminationOT 5018 Thesis Dissemination
OT 5018 Thesis Dissemination
 
Ot5101 005 week 5
Ot5101 005 week 5Ot5101 005 week 5
Ot5101 005 week 5
 
Ot5101 005 week4
Ot5101 005 week4Ot5101 005 week4
Ot5101 005 week4
 
Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors
 
Ch 5 developmental stages of the learner
Ch 5   developmental stages of the learnerCh 5   developmental stages of the learner
Ch 5 developmental stages of the learner
 
OT 5101 week2 theory policy
OT 5101 week2 theory policyOT 5101 week2 theory policy
OT 5101 week2 theory policy
 
OT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentOT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessment
 
Ot5101 week1
Ot5101 week1Ot5101 week1
Ot5101 week1
 
NUR 304 Chapter005
NUR 304 Chapter005NUR 304 Chapter005
NUR 304 Chapter005
 
NUR 3043 Chapter007
NUR 3043 Chapter007NUR 3043 Chapter007
NUR 3043 Chapter007
 
NUR 3043 Chapter006
NUR 3043 Chapter006NUR 3043 Chapter006
NUR 3043 Chapter006
 
NUR 3043 Chapter004
NUR 3043 Chapter004NUR 3043 Chapter004
NUR 3043 Chapter004
 
3043 Chapter009
3043 Chapter0093043 Chapter009
3043 Chapter009
 
3043 Chapter008
 3043 Chapter008 3043 Chapter008
3043 Chapter008
 
Melnyk ppt chapter_21
Melnyk ppt chapter_21Melnyk ppt chapter_21
Melnyk ppt chapter_21
 
Melnyk ppt chapter_22
Melnyk ppt chapter_22Melnyk ppt chapter_22
Melnyk ppt chapter_22
 

Ppt chapter 58

  • 1. Drugs Affecting Gastrointestinal Motility Chapter 58 Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 2. Actions of Drugs Used to Affect Motor Activity of the GI Tract • Speed up or improve movement of intestinal contents when movement becomes slow or sluggish (constipation) • Increase the tone of the GI tract and stimulate motility throughout the system • Decrease movement along the GI tract when rapid movement decreases the time for absorption of nutrients (diarrhea) Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 3. Sites of Action of Drugs Affecting GI Motility Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 4. Types of Laxatives • Chemical Stimulants – Chemically irritate the lining of the GI tract • Bulk Stimulants – Cause the fecal matter to increase in bulk Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Lubricants – Help the intestinal contents move more smoothly
  • 5. Types of Chemical Stimulants • Cascara (Generic): Reliable agent that leads to intestinal evacuation • Senna (Senokot): Reliable drug, similar to cascara (OTC) • Castor Oil (Neoloid): Old standby for thorough evacuation of the intestine • Bisacodyl (Dulcolax): Very popular OTC laxative Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 6. Types of Bulk Stimulants • Magnesium Sulfate (Epsom Salts) • Magnesium Citrate (Citrate of Magnesia) • Magnesium Hydroxide (Milk of Magnesia) • Lactulose (Chronulac) • Polycarbophil (FiberCon) • Psyllium (Metamucil) Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 7. Types of Lubricating Laxatives • Docusate (Colace) – Has a detergent action on the surface of the intestinal bolus, making a softer stool • Glycerin (Sani-Supp) – Hyperosmolar laxative used to gently evacuate the rectum without systemic effects higher in the GI tract • Mineral Oil (Agoral Plain) – Forms a slippery coat on the contents of the intestinal tract Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 8. Laxatives Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Work in three ways: • Direct chemical stimulation of the GI tract • Production of bulk or increased fluid in the lumen • Lubrication of the intestinal bolus to promote passage through the GI tract • Indications – Short-term relief of constipation – Prevent straining when it is clinically undesirable – Evacuate the bowel for diagnostic procedures – Removal of ingested poisons – Adjunct in antihelmintic therapy
  • 9. Laxatives (cont.) • Pharmacokinetics – Only minimally absorbed and exert their therapeutic effect directly in the GI tract • Contraindications – Acute abdominal disorders Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Caution – Pregnancy or lactation
  • 10. Laxatives (cont.) • Adverse Effects – GI effects - Diarrhea, abdominal cramping, and Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins nausea – CNS effects – Dizziness, headache, and weakness – CV effects – Sweating, palpitations, flushing, and fainting – Cathartic dependency • Drug-to-Drug Interactions – Some interfere with the timing or process of absorption
  • 11. Question Which of the following is a very popular OTC laxative? A. Cascara B. Magnesium citrate C. Bisacodyl D. Polycarbophil Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 12. Answer C. Bisacodyl Rationale: Bisacodyl (Dulcolax): Very popular OTC laxative. Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 13. Types of Gastrointestinal Stimulants • Dexpanthenol (Ilopan) – Increases acetylcholine levels and stimulates the parasympathetic system • Metoclopramide (Reglan) – Blocks dopamine receptors and makes the GI cells more sensitive to acetylcholine – Leads to increased GI activity and rapid movement of food through the upper GI tract Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 14. Gastrointestinal Stimulants Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Stimulate parasympathetic activity within the GI tract – Increase GI secretions and motility • Indications – Rapid movement of GI contents is desirable • Pharmacokinetics – Rapidly absorbed – Metabolized in the liver – Excreted in the urine
  • 15. Gastrointestinal Stimulants (cont.) • Contraindications – Allergy – GI obstruction Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Caution – Pregnancy – Lactation
  • 16. Gastrointestinal Stimulants (cont.) • Adverse Effects – Nausea, vomiting, diarrhea, intestinal spasms, cramping, decreased blood pressure and heart rate, weakness, and fatigue • Drug-to-Drug Interactions – Digoxin – Cyclosporine – Alcohol Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 17. Types of Antidiarrheal Drugs • Bismuth Subsalicylate (Pepto-Bismol): Coats the lining of the GI tract and soothes irritation stimulating local reflexes to cause excessive GI activity and diarrhea • Loperamide (Imodium): Has a direct effect on the muscle layers of the GI tract; slows peristalsis and allows increased time for absorption of fluid and electrolytes • Opium Derivatives (Paregoric): Stimulates spasm within the GI tract, stops peristalsis and diarrhea Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 18. Antidiarrheal Drugs Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Slow the motility of the GI tract through direct action on the lining of the GI tract • Indications – Relief of symptoms of acute or chronic diarrhea – Reduction of volume of discharge from ileostomies – Prevention and treatment of traveler’s diarrhea • Pharmacokinetics – Vary depending on agent
  • 19. Antidiarrheal Drugs (cont.) • Contraindications Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins – Allergy • Caution – Pregnancy – Lactation – History of GI obstruction – History of acute abdominal conditions – Diarrhea due to poisonings
  • 20. Antidiarrheal Drugs (cont.) • Adverse Effects – Constipation – Abdominal distension – Abdominal discomfort – Nausea – Dry mouth – Toxic megacolon – Fatigue – Weakness – Dizziness Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 21. Antidiarrheal Drugs (cont.) • Drug-to-Drug Interactions – Depends on the drug Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 22. Question Please answer the following statement as true or false. Pepto-Bismol can be involved in salicylate toxicity. Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 23. Answer True Rationale: Bismuth Subsalicylate (Pepto-Bismol) coats the lining of the GI tract and soothes irritation stimulating local reflexes to cause excessive GI activity and diarrhea. Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 24. Use of Laxative and Antidiarrheal Agents Across the Lifespan Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 25. Prototype Chemical Stimulant Laxative Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 26. Prototype Bulk Laxative Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 27. Prototype Lubricant Laxative Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 28. Prototype Gastrointestinal Stimulants Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 29. Prototype Antidiarrheal Drugs Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 30. Nursing Considerations for Laxatives • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 31. Nursing Considerations for Gastrointestinal Stimulants • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 32. Nursing Considerations for Antidiarrheal Drugs • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 33. Question Why should laxatives be taken only on a short-term basis? A. To prevent a fluid volume deficit B. To prevent cathartic dependence C. To obtain relief of abdominal distention D. To obtain relief of intestinal cramping Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 34. Answer B. To prevent cathartic dependence Rationale: Administer laxative only as a temporary measure to prevent development of cathartic dependence. Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins